SCHAEFFER; Merrill Lynn

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHAEFFER; Merrill Lynn.The latest application filed is for "methods of manufacturing an immunogenic composition comprising a recombinant protein".

Company Profile

5.14.13

SCHAEFFER; Merrill Lynn - St. Joseph MO
Schaeffer; Merrill Lynn - Ridgefield CT
Schaeffer; Merrill Lynn - Saint Joseph MO US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Manufacturing An Immunogenic Composition Comprising A Recombinant Protein App 20200345834 - STARKS; Andrea J. Headrick ; et al.	2020-11-05
Quantification of vaccine compositions Grant 10,767,213 - Eichmeyer , et al. Sep	2020-09-08
PCV2 immunogenic compositions and methods of producing such compositions Grant 10,576,142 - Eichmeyer , et al.	2020-03-03
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Grant 10,568,955 - Roof , et al. Feb	2020-02-25
Marker system, in particular for baculovirus-expressed subunit antigens Grant 10,545,148 - Iyer , et al. Ja	2020-01-28
Marker System, In Particular For Baculovirus-expressed Subunit Antigens App 20190154688 - Iyer; Arun V. ; et al.	2019-05-23
Marker system, in particular for baculovirus-expressed subunit antigens Grant 10,168,330 - Iyer , et al. J	2019-01-01
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs App 20180236057 - Roof; Michael B. ; et al.	2018-08-23
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions App 20180169214 - Eichmeyer; Marc Allan ; et al.	2018-06-21
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Grant 9,987,349 - Roof , et al. June 5, 2	2018-06-05
Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof App 20180147278 - KLOCKE; Sonja ; et al.	2018-05-31
PCV2 immunogenic compositions and methods of producing such compositions Grant 9,919,041 - Eichmeyer , et al. March 20, 2	2018-03-20
Quantification Of Vaccine Compositions App 20170253908 - Eichmeyer; Marc Allan ; et al.	2017-09-07
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Grant 9,669,087 - Roof , et al. June 6, 2	2017-06-06
Quantification of vaccine compositions Grant 9,624,527 - Eichmeyer , et al. April 18, 2	2017-04-18
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Grant 9,610,345 - Roof , et al. April 4, 2	2017-04-04
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs App 20170049875 - Roof; Michael B. ; et al.	2017-02-23
Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity Grant 9,561,270 - Kohler , et al. February 7, 2	2017-02-07
Marker System, In Particular For Baculovirus-expressed Subunit Antigens App 20160258953 - IYER; Arun V. ; et al.	2016-09-08
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs App 20160193320 - Roof; Michael B. ; et al.	2016-07-07
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs App 20150190498 - Roof; Michael B. ; et al.	2015-07-09
PCV2 immunogenic compositions and methods of producing such compositions Grant 9,011,872 - Eichmeyer , et al. April 21, 2	2015-04-21
Quantification Of Vaccine Compositions App 20140248603 - EICHMEYER; Marc Allan ; et al.	2014-09-04
Methods Of Reducing Virucidal Activity In Pcv-2 Compositions And Pcv-2 Compositions With An Improved Immunogenicity App 20110059126 - Kohler; Caroline Ann ; et al.	2011-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.